文献速递泌尿生殖与妇科肿瘤放疗

根治性前列腺切除术后挽救性放疗:RADICALS-RT 试验中按剂量分割方案分析的毒性

Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2023-05-06

RADICALS-RT 试验的非随机探索性分析纳入 634 例术后辅助放疗患者,其中 217 例(34%)计划接受 52.5 Gy/20 次、417 例(66%)接受 66 Gy/33 次。两种方案严重毒性均少见,仅 66 Gy/33 次组前 2 年 1–2 级膀胱炎报告率较高(20% vs 30%,P = .04),患者报告结局两组差异无临床意义。

要点

  • 52.5 Gy/20 次与 66 Gy/33 次方案严重毒性均罕见。
  • 前 2 年 1–2 级膀胱炎 52.5 Gy/20 次组 20% vs 66 Gy/33 次组 30%(P = .04)。
  • 2 年后 1–2 级膀胱炎 66 Gy 组 16% vs 52.5 Gy 组 9%(P = .08)。

核心结论

  • 前列腺床放疗采用 52.5 Gy/20 次或 66 Gy/33 次方案后严重毒性均罕见,两种方案在毒性或患者报告结局上仅记录到适度差异。

研究设计与样本

  • RADICALS-RT 试验的非随机探索性分析,纳入 634 例术后辅助放疗患者,按计划放疗剂量分割方案分组比较毒性。

主要发现

  • 634 例中 217 例(34%)计划接受 52.5 Gy/20 次,417 例(66%)计划接受 66 Gy/33 次。
  • 前 2 年 1–2 级膀胱炎在 66 Gy/33 次组报告更频繁(52.5 Gy/20 次组 20% vs 66 Gy/33 次组 30%;P = .04)。
  • 2 年后 1–2 级膀胱炎在 66 Gy 组为 16%、52.5 Gy 组为 9%(P = .08)。
  • 其他毒性反应两组相似,极少数患者出现任何 3–4 级毒性反应。
  • 患者报告 1 年时泌尿与粪便失禁评分略高于基线,但 52.5 Gy/20 次组与 66 Gy/33 次组间无临床意义差异;患者报告健康状况在基线与 1 年时相似且两组间相似。

关键数值与推荐

  • 放疗剂量信息在所有患者中收集;放疗肿瘤学组毒性评分每 4 个月记录 1 次共 2 年,之后每 6 个月至 5 年,再每年至 15 年。
  • 患者报告数据在基线与 1、5、10 年使用标准量表收集,包括 Vaizey 粪便失禁评分(肠道)与国际尿失禁学会男性简表问卷(泌尿失禁)。
  • 记录前 2 年内及 2 年后最高事件级别,采用 χ² 检验比较治疗组间差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Emerging data indicate comparable disease control and toxicity of normal postoperative fractionation and moderate hypofractionation radiation therapy (RT) in prostate cancer. In RADICALS-RT, patients were planned for treatment with either 66 Gy in 33 fractions (f) over 6.5 weeks or 52.5 Gy in 20f over 4 weeks. This non-randomized, exploratory analysis explored the toxicity of these 2 schedules in patients who had adjuvant RT. METHODS AND MATERIALS: Information on RT dose was collected in all patients. The Radiation Therapy Oncology Group toxicity score was recorded every 4 months for 2 years, every 6 months until 5 years, then annually until 15 years. Patient-reported data were collected at baseline and at 1, 5, and 10 years using standard measures, including the Vaizey fecal incontinence score (bowel) and the International Continence Society Male Short-Form questionnaire (urinary incontinence). The highest event grade was recorded within the first 2 years and beyond 2 years and compared between treatment groups using the χ² test. RESULTS: Of 634 patients, 217 (34%) were planned for 52.5 Gy/20f and 417 (66%) for 66 Gy/33f. In the first 2 years, grade 1 to 2 cystitis was reported more frequently among the 66 Gy/33f group (52.5 Gy/20f: 20% vs 66 Gy/33f: 30%; P = .04). After 2 years, grade 1 to 2 cystitis was reported in 16% in the 66-Gy group and 9% in the 52.5-Gy group (P = .08). Other toxic effects were similar in the 2 groups, and very few patients had any grade 3 to 4 toxic effects. Patients reported slightly higher urinary and fecal incontinence scores at 1 year than at baseline, but no clinically meaningful differences were reported between the 52.5 Gy/20f and 66 Gy/33f groups. Patient-reported health was similar at baseline and at 1 year and similar between the 52.5 Gy/20f and 66 Gy/33f groups. CONCLUSIONS: Severe toxic effects were rare after prostate bed radiation therapy with either 52.5 Gy/20f or 66 Gy/33f. Only modest differences were recorded in toxic effects or in patient-reported outcomes between these 2 schedules.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Petersen PM, Cook AD, Sydes MR, et al. Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial. Int J Radiat Oncol Biol Phys. 2023. PMID: 37150260. doi:10.1016/j.ijrobp.2023.04.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。